Low-Dose Chemotherapy to Treat Burkitt Lymphoma

High dose chemotherapy has been the conventional approach to treating Burkitt Lymphoma (“BL”), one of the more aggressive forms of this disease.  However, long-term survival rates following this treatment approach have hovered only around 60% (and, of course, such treatment is highly toxic in itself, with onerous side effects).  A recent study sponsored by the National Institute […]